Cost-effective diagnostic checklists for meningitis in resource-limited settings.
about
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastCryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisPredictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation.Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100.Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.Methods of rapid diagnosis for the etiology of meningitis in adultsStandardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings.Utility of the Xpert MTB/RIF assay for diagnosis of tuberculous meningitis.Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.The Epidemiology of Meningitis among Adults in a South African Province with a High HIV Prevalence, 2009-2012Altered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi.The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrumCerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda.Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF.Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitisEfficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.Meningitis in HIV-positive patients in sub-Saharan Africa: a review.Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Syndromic Panel-Based Testing in Clinical Microbiology.Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.Immunology of Cryptococcal Infections: Developing a Rational Approach to Patient Therapy.Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan AdultsDelta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitisCan improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaCerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal MeningitisApplication of Dendrimers for the Treatment of Infectious DiseasesOutcome of patients with acute bacterial meningitis in a teaching hospital in Ethiopia: A prospective study
P2860
Q24620256-2A0F3744-45B6-4D18-BFF0-FA5225FA0FEDQ28274334-D2E95E7C-FF39-4757-ADE6-838184DC2D6FQ33663591-5E9A0431-5E71-47FA-96A3-B657931D916EQ33747751-4EAF1247-B7D0-4822-A1EE-32BB9DD7D19DQ33765829-8BB159ED-4740-4897-9FEE-4F7BC4CEEA95Q33982206-2B0E22DF-9F57-41EE-A958-66E567FBD365Q34024416-099520B6-0043-43B9-B051-333505DBBB31Q34554521-89F727F2-49BC-4621-9E8E-FB52A158B47DQ34801921-67DD9041-9DF4-4597-9F08-76750ACBF147Q35027620-66296155-367B-43C2-A273-A04DF1F2A1B3Q35531947-49719119-7B60-4503-B080-6942CB487E47Q35855950-C958ED97-D2D3-42F7-B1F3-B096CDEA68E3Q35880502-DD64E90D-502E-4F4D-9611-3E5A28F10463Q36145111-F6EA7F50-9C61-4318-91B1-FD02D5E366BBQ36362294-AFA60A61-E518-4A09-A1A4-ABD8F3FD0987Q36399747-8E4C54CB-015B-429F-B005-9AA1615E9A9CQ36407524-CE113D85-6F40-4F8C-B1DF-A460C827CE09Q36463811-D7B654C3-F6C8-46A1-89AF-B079706592AAQ36488971-D0CFC430-F883-43DE-94EB-376B0D20D196Q36609745-F3549E3B-FEF5-4470-AEE7-DFF25C687612Q36622358-F0338A5A-325F-44B1-8A05-5286828BDFF3Q36807382-6F78C9C7-2B4C-45B2-B155-DB5A084DCFB6Q37052988-ECD7D8E3-610C-4F16-BD26-13D7209D91E0Q37215923-B08E8B46-4DF5-44D2-9D4C-937945BFA59AQ37395571-4B8D47CB-D5BB-4DDD-8E07-CF0BD5C3570FQ38259519-C60D3906-E545-4549-A708-CFC73137AF9AQ38849478-4079F98D-E4FB-47D9-B20A-DD3BFC4596D5Q38851467-A0B9A689-B350-4F98-93FB-2EB675A578CCQ39379643-7E8C1B5E-C6E7-4541-9128-6F0A592297ACQ41997232-74D42368-E171-4F19-BF10-FC9362CF28C2Q47646979-9684067D-A109-41FD-9962-1FC919D56280Q47710544-08406008-9DBF-47F5-9B28-DED5CAF9CA46Q48303014-EE173B60-1AED-4DA7-AA28-41494647E639Q54953513-771D378D-5EF1-4C34-903B-7A94DC1764C5Q56910027-C4F602FB-EFEB-47F6-8906-B41957A9C068Q56911556-F18E0CBB-B566-434F-98EB-F775483D6519Q56912105-0268A83D-507E-4D20-9CE1-78D3E9606162Q56912245-96E8E352-D214-452E-8714-CA21D75F1DC3Q58696083-9E011D05-93C9-434E-9E34-525F10976A38Q58843432-5AB45D8A-691E-4288-B67A-267411111DC4
P2860
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@ast
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@en
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@nl
type
label
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@ast
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@en
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@nl
prefLabel
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@ast
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@en
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@nl
P2093
P2860
P1476
Cost-effective diagnostic checklists for meningitis in resource-limited settings.
@en
P2093
Beth A Virnig
Kara N Durski
Karen M Kuntz
Kosuke Yasukawa
P2860
P304
P356
10.1097/QAI.0B013E31828E1E56
P407
P577
2013-07-01T00:00:00Z